Le mode conseil est activé Arrêter

XDNA - iShares Genomics Immunology and Healthcare Index ETF (CAD) (CA46437W1059)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
CA46437W1059
XDNA ISIN
Fonds négociés en bourse (FNB)
Type de fonds
BlackRock
Fournisseur
-
valeur liquidative par action
26/04/2022
Date de lancement
2 fois par an
Paiement de dividendes
CEOJLU
CFI
XDNA
Ticker
Formed
Status
Equity
Objet d'investissement
Healthcare
Secteur
Global
Géographie
NYSE FactSet Global Genomics and Immuno Biopharma Index
Benchmark
0.39 %
Ratio de coût total
Physical
Méthode de réplication
9,59 mln CAD
Actif total du fonds | 21/07/2026
9,59 mln CAD
Volume des actits de classe "actions" | 21/07/2026
Non
UCITS

Rendement au 23/07/2026, Toronto SE

  • YTD
    9,51 %
  • 1M
    -7,03 %
  • 3M
    0,05 %
  • 6M
    9,54 %
  • 1Y
    46,69 %
  • 3Y
    21,12 %
  • 5Y
    -
  • 10Y
    -
Au prix de la bourse, avec prise en compte des paiements

Dernières données pour
Ajouter à comparer

Cotations (XDNA)

Explorer la base de données la plus complète

1 000 000

obligations

100 000

actions

175 910

ETF & Funds

100 000

indices

Suivre votre portefeuille de la manière la plus efficace

  • Screener d'obligations
  • liste de surveillance
  • Excel ADD-IN

Dynamique des prix

Fund profile

The iShares Genomics Immunology and Healthcare Index ETF seeks to replicate as close as possible the price and yield performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

XDNA profile

The iShares Genomics Immunology and Healthcare Index ETF (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The BlackRock fund’s base currency is CAD and the share class was registered 26.04.2022 with unique ISIN - CA46437W1059. Main exchange is Toronto SE and ticker symbol is XDNA. The total expense ratio is 0.39%. The iShares Genomics Immunology and Healthcare Index ETF (CAD) pays dividends 2 time(s) per year.

Structure XDNA au 22/07/2026

Titre Valeur
CAD CASH 11,19%
TWIST BIOSCIENCE CORP 4,93%
BAYER AG 4,64%
REVOLUTION MEDICINES INC 4,44%
MODERNA INC 4,43%
GENMAB 4,29%
INCYTE CORP 4,09%
TAKEDA PHARMACEUTICAL LTD 4,01%
VERTEX PHARMACEUTICALS INC 3,83%
MERCK & CO INC 3,82%
BIONTECH SE ADR 3,78%
EXELIXIS INC 3,78%
REGENERON PHARMACEUTICALS INC 3,71%
IPSEN SA 3,68%
ROCHE PS PAR AG 3,59%
GLAXOSMITHKLINE 3,57%
SANOFI SA 3,52%
IDEAYA BIOSCIENCES INC 3,31%
IMMUNITYBIO INC 3,21%
ARCUS BIOSCIENCES INC 2,85%
IOVANCE BIOTHERAPEUTICS INC 2,28%
CARIS LIFE SCIENCES INC 2,14%
ONO PHARMACEUTICAL LTD 1,89%
NUVATION BIO INC CLASS A 1,84%
CRISPR THERAPEUTICS AG 1,54%
ABCELLERA BIOLOGICS INC 1,53%
VIR BIOTECHNOLOGY INC 1,42%
NOVAVAX INC 1,4%
KURA ONCOLOGY INC 1,03%
GENFLEET THERAPEUTICS (SHANGHAI) I 1,03%
JANUX THERAPEUTICS INC 1,02%
CORVUS PHARMACEUTICALS INC 1%
PERSONALIS INC 0,88%
RIGEL PHARMACEUTICALS INC 0,77%
SUNSHINE LAKE PHARMA LTD CLASS H 0,76%
CYTOMX THERAPEUTICS INC 0,66%
VERASTEM INC 0,55%
INTELLIA THERAPEUTICS INC 0,54%
SHANGHAI HENLIUS BIOTECH INC H 0,53%
DESIGN THERAPEUTICS INC 0,5%
XENCOR INC 0,5%
OCUGEN INC 0,49%
VALNEVA 0,45%
PACIFIC BIOSCIENCES OF CALIFORNIA 0,45%
GINKGO BIOWORKS HOLDINGS INC CLASS 0,41%
ALVOTECH SA 0,41%
ABCLON INC 0,24%
PRIME MEDICINE INC 0,1%
OMNIAB INC $15.00 VESTING Prvt 0%
ARCELLX INC CVR 0%
TWD CASH 0%
GBP/USD 0%
DKK/USD 0%
JPY/USD 0%
CHF/USD 0%
HKD/USD 0%
KRW/USD 0%
OMNIAB INC $12.50 VESTING Prvt 0%
EUR/USD 0%
CAD/USD 0%
KRW CASH -0,03%
HKD CASH -0,25%
CHF CASH -0,39%
GBP CASH -0,39%
DKK CASH -0,47%
JPY CASH -0,64%
EUR CASH -1,36%
USD CASH -7,48%
Autres - %

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Valeur nette d'actifs
    {{ item.expense_ratio }}
    Ratio de coût total
Vous devez vous inscrire pour y accéder.